One would hope that increases in the number of centers that are enrolling patients and word of mouth amongst practitioners around the effectiveness of MSCs in ARDS would see a continuing uptick in the speed of enrollment, so maybe the remaining 50% can be done faster than the initial 50%.
Anyway, the fact that we are now past the 45%, and likely quite near the 60%, means for certain that SI's comments about an "early November" review by the DSMB is spot on and an announcement thereabouts is a lock.
- Forums
- ASX - By Stock
- MSB
- Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
MSB
mesoblast limited
Add to My Watchlist
1.30%
!
$2.28

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.28 |
Change
-0.030(1.30%) |
Mkt cap ! $2.918B |
Open | High | Low | Value | Volume |
$2.32 | $2.39 | $2.24 | $12.37M | 5.361M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 28219 | $2.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.14 | 124 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 72 | 2.400 |
6 | 30668 | 2.390 |
22 | 39985 | 2.350 |
5 | 44241 | 2.340 |
1 | 4427 | 2.300 |
Price($) | Vol. | No. |
---|---|---|
2.140 | 124 | 2 |
2.160 | 546 | 3 |
2.170 | 26225 | 8 |
2.230 | 39161 | 15 |
2.260 | 168 | 4 |
Last trade - 15.59pm 22/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |